AGP Executive Report
Last update: 4 minutes agoMeasles Alert: The U.S. has lost its measles elimination status after sustained transmission. A new analysis warns pregnant people may face sharply higher risks of severe illness, underscoring the stakes of vaccination. Drug Costs: At a Senate hearing, Sen. Katie Britt pressed industry leaders on rising prescription prices; suggestions included out-of-pocket caps and changes to drug pricing and reimbursement. Medication Safety: The FDA will require GLP-1 labels to warn about rare, potentially sight-threatening NAION. Studies show an association, but have not established that the drugs cause it. Cancer Research: A University of Chicago team reports that radiation-activated CAR-T cells shrank tumors more effectively in a study, offering a potential approach to hard-to-treat solid cancers. Gut Health: Researchers engineered hard-to-study gut bacteria to produce a protective immune protein; in mice, the modified microbes improved symptoms of metabolic liver disease. Healthcare AI: CMS has outlined a federal plan to speed clinical AI adoption while addressing patient safety, privacy, cybersecurity and bias.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.